Navigation Links
OriGene Technologies Launches Over 5,000 Heavy Isotope Labeled Full-Length Human Proteins as Quantitative Internal Standards for SRM/MRM Mass Spectrometry
Date:6/3/2010

ROCKVILLE, Md., June 3 /PRNewswire/ -- OriGene Technologies, Inc., a leading gene-centric life sciences company, has announced the first of its kind launch of over 5,000 heavy isotope labeled human proteins as internal standards for SRM/MRM (single reaction monitoring, multiple reaction monitoring) mass spectrometry analyses. The announcement was made at the 2010 American Society for Mass Spectrometry conference in Salt Lake City, Utah.

Mass spectrometry, especially MRM, has emerged as a new platform for quantitative characterization of multiple proteins, thus making it an ideal choice for high throughput proteomics and clinical biomarker research.  A critical bottleneck in SRM/MRM application is the lack of quantitative internal standards for all protein targets. With the newly released 5,000 heavy isotope labeled protein standards, researchers can simply mix the standards with their samples and perform protein quantification without the need of expensive and time-consuming peptide synthesis.  Compared to heavy labeled AQUA peptides, heavy labeled full-length proteins can be spiked at earlier stage of sample preparation and would allow more accurate targeted protein quantitation over complete analysis process, from sample extraction, fractionation, HPLC, and MS analysis. In addition to the initial 5,000 labeled human full-length protein standards, OriGene plans to add to its mass spectrometry offering of custom protein labeling, labeled transfected lysates, and eventually labeled peptide standards for all human proteins.

About OriGene Technologies

OriGene Technologies, Inc., is a gene centric life sciences company dedicated to support academic, pharmaceutical and biotech companies in their research of gene functions and drug discovery. OriGene develops proteins, antibodies, and other molecular tools to allow researchers to analyze their data on a multiplex level. OriGene's novel product line includes the world's largest cDNA and shRNA clone collections, over 5,000 purified human proteins, high quality monoclonal antibodies (TrueMAB™), 100,000 highly validated human tissues, and protein microarray products and services.  OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. For more information, visit www.origene.com.


'/>"/>
SOURCE OriGene Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. OriGene Technologies, Inc. to Build the Worlds Largest TrueMAB(TM) Monoclonal Antibody Facility in Wuxi, China
2. OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome
3. OriGene Technologies Acquires Marligen Biosciences
4. OriGene Launches 5,000 Purified Human Proteins from HEK293 Cells
5. OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China
6. OriGene Announces 37,000 ORF cDNA Clones in a GFP Vector
7. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
8. Reportlinker Adds Biomarkers - Technologies, Markets and Companies
9. Plant BioTech World Congress to Highlight Scientific Discoveries and Technologies Bringing New Hope to Feeding the World and Improving Lives
10. Sensient Technologies Corporation Announces Major Investment in Natural Colors
11. Hothead Technologies Partners with Sivix Logistics to Add Customized Handheld Monitors and Autonomous Sensors to its Product Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... 22, 2017 , ... Baltimore biotech firm, PathSensors, announced that ... in developing and issuing recommendations to grow Maryland's biohealth industry and position the ... , The recommendations are contained in a report from the ...
(Date:5/21/2017)... ... 20, 2017 , ... CNSDose is a genetically driven, clinically ... by finding the right antidepressant faster. CNSDose speeds recovery and reduces side ... personalized approach to treatment. , A peer-reviewed and published, 12-week double-blind ...
(Date:5/18/2017)... Malden, Mass. (PRWEB) , ... May 18, 2017 ... ... completed the procedure on April 28, 2017 at the Prince Of Wales Private ... degenerative cervical disc at level C6-C7. The patient failed conservative treatments prior to ...
(Date:5/18/2017)... ... May 17, 2017 , ... NDA Partners Chairman Carl ... CEO of Eurofins Advantar Laboratories and President of Pharmaceutical Development Business Unit of Cardinal ... at Eurofins and Cardinal Health, he was former Chief Operating Officer at Anaborex, Senior ...
Breaking Biology Technology:
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):